|
Yesterday, Moderna filed for emergency use authorization for its COVID-19 vaccine. Vaccine trials have shown the drug to be 94% effective against the disease.
We are pleased to announce that Scott Nickerson, the Site Head of Moderna’s Manufacturing Facility and Senior VP of US Manufacturing, will be the guest speaker at our Annual Meeting and Awards event on Friday, January 22nd from 12:00 - 1:00 PM. Mr. Nickerson will share with us information about Moderna's ability to develop a successful vaccine in less than a year. The Annual Meeting will be held virtually this year and in addition to the guest speaker will feature our election of officers and directors and our annual awards presentations. Registration will be open soon. We are adapting our Annual Awards this year to focus on businesses and individuals who have responded uniquely to the challenges presented by COVID-19. Please help us recognize a business or person you know that has done something special to help others during the pandemic or who has changed their business model to find success in new ways. This could include making or distributing Personal Protective Equipment (PPE), frontline workers, or anything else that is a positive response to the pandemic. Download the Nomination Form Tom O'Rourke, CCE President and CEO Comments are closed.
|
